Liyi Zhang
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PTPIP51 inhibits non-small-cell lung cancer by promoting PTEN-mediated EGFR degradation.
Journal: Life sciences
Published: October 05, 2021
Study on Genetype in Lung Squamous Carcinoma by High-throughput of Transcriptome Sequence
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: November 24, 2017
Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 28, 2016
Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.
Journal: Cancer science
Published: May 27, 2016
LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle.
Journal: Oncotarget
Published: February 01, 2016
Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.
Journal: International journal of oncology
Published: November 28, 2015
Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 22, 2015
Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 11, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026